Cumberland Pharmaceuticals to submit New Drug Application for ifetroban

Labcorp, Charles River and FDA collaborate on advancing preclinical methods for evaluating drug abuse potential

ProBio's Nanjing biologics manufacturing facility completes Chinese regulatory pre-approval inspection

Lynch Regenerative Medicine's Phase IIb clinical trial of rhPDGF-BB injection cleared by FDA

European Commission approves Novartis' Cosentyx for polymyalgia rheumatica

Edwards Lifesciences wins FDA approval for PASCAL Precision tricuspid repair system

GSK wins US FDA approval for chronic hepatitis B treatment Hibsago

Solventum's combined use of Restrata Matrix and Solventum VAC Therapy receives FDA 510(k) clearance

Vivacta Bio and Grit Bio's in vivo CAR-T therapy GT801 receives US FDA Orphan Drug Designation for autoimmune haemolytic anaemia

Viatris' RYZUMVI receives US FDA Approval to treat presbyopia

Omeros receives negative EU opinion on narsoplimab after re-examination

Ionis' TRYNGOLZA recommended for EU approval in severe hypertriglyceridemia

FDA approves Genentech's Enspryng as first at-home subcutaneous treatment for thyroid eye disease

Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer